A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Enalapril in Patients With Clinical Diabetic Nephropathy
- 1 November 1992
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 20 (5) , 443-457
- https://doi.org/10.1016/s0272-6386(12)70256-1
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The Natural History and Epidemiology of Diabetic NephropathyPublished by American Medical Association (AMA) ,1990
- Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy.BMJ, 1990
- Hemodynamic, Renal, and Humoral Effects of the Calcium Entry Blocker Nicardipine and Converting Enzyme Inhibitor Captopril in Hypertensive Type II Diabetic Patients with NephropathyJournal of Cardiovascular Pharmacology, 1989
- Diabetic Nephropathy: Hemodynamic Basis and Implications for Disease ManagementAnnals of Internal Medicine, 1989
- Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive Type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trialDiabetologia, 1989
- Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.BMJ, 1988
- Captopril in patients with type II diabetes and renal insufficiency: Systemic and renal hemodynamic alterationsThe American Journal of Medicine, 1988
- Hormonal and Metabolic Effects of Enalapril Treatment in Hypertensive Subjects With NIDDMDiabetes Care, 1988
- Microalbuminuria as a predictor of clinical diabetic nephropathyKidney International, 1987
- Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy.BMJ, 1986